Variation in innate immunity genes and risk of multiple myeloma

Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myeloma

(2010) L. POUR et al.   NEOPLASMA

Insulin-like Growth Factor-1- and Interleukin-6-related Gene Variation and Risk of Multiple Myeloma

(2009) B. M. Birmann et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Treatment response to bortezomib in multiple myeloma correlates with plasma hepatocyte growth factor concentration and bone marrow thrombospondin concentration

(2009) Pour Ludek et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies

(2009) S. Y. Kristinsson et al.   HAEMATOLOGICA

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma

(2008) S. Y. Kristinsson et al.   BLOOD

A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma

(2008) Mark P. Purdue et al.   CARCINOGENESIS

Common genetic variants associated with plasma fibrin D-dimer concentration in older European- and African-American adults

(2008) L. A. LANGE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS